STABILITY OF NIZATIDINE IN EXTEMPORANEOUS ORAL LIQUID PREPARATIONS

被引:7
|
作者
LANTZ, MD [1 ]
WOZNIAK, TJ [1 ]
机构
[1] ELI LILLY INT CORP,LILLY RES LAB,DIV ANALYT DEV,MC769,INDIANAPOLIS,IN 46285
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1990年 / 47卷 / 12期
关键词
Aluminum hydroxide; Antacids; Beverages; Dissolution; Gastrointestinal drugs; Hydrogen ion concentration; Incompatibilities; Juices; Magnesium hydroxide; Nizatidine; Stability; Storage; Temperature;
D O I
10.1093/ajhp/47.12.2716
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of nizatidine in extemporaneous oral liquid preparations stored at room and refrigerated temperatures was studied. Preparations containing nizatidine in a final concentration of approximately 2.5 mg/mL were made by mixing the contents of a 300-mg nizatidine capsule with commercial juices (Gatorade, Stokely-Van Camp; Cran-Grape, Ocean Spray; apple juice, Sundor Brands; and V8 vegetable juice, Campbell Soup) and with aluminum hydroxide-magnesium hydroxide suspension (Maalox, Rorer). A control solution was prepared in water. Samples of each preparation were stored at 15-30 °C and at 5 °C. Initially and after 4, 8, 24, and 48 hours of storage, the samples were visually inspected, tested for pH, and analyzed in triplicate by high-performance liquid chromatography for nizatidine content. No appreciable changes in appearance or pH occurred. The only extemporaneous preparations with greater than 10% loss of nizatidine potency at 48 hours were the Cran-Grape and V8 preparations at room temperature. There was no correlation between pH of the preparations and changes in drug concentration. In the Maalox and V8 preparations, the drug powder did not dissolve uniformly. In all the preparations tested, nizatidine was stable for at least eight hours at refrigerated and room temperatures. In all except the Cran-Grape and V8 preparations, the drug was stable for 48 hours under both storage conditions.
引用
收藏
页码:2716 / 2719
页数:4
相关论文
共 50 条
  • [21] Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
    Fadda, Hala M.
    Weiler, Hannah
    Carvalho, Maria
    Lee, You Zhuan
    Dassouki, Hadi
    Abublan, Rasha
    Iurian, Sonia
    Hamid, Aasma
    Seremet, Gokhan
    Li, Zhiping
    Tuleu, Catherine
    Minghetti, Paola
    Pauletti, Giovanni M.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 204
  • [22] PROBLEMS IN PRESCRIBING OF EXTEMPORANEOUS PREPARATIONS IN SLOVENIA
    BUDIHNA, MV
    TURK, K
    SMIDKORBAR, J
    ZDRAVSTVENI VESTNIK, 1990, 59 (7-8): : 369 - 374
  • [23] Dapsone for topical use in extemporaneous preparations
    Wohlrab, Johannes
    Michael, Julia
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (01): : 34 - 40
  • [24] Spectrophotometric determination of nizatidine in pharmaceutical preparations
    Minic, D
    Petkovic, J
    Koricanac, Z
    Jovanovic, T
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (8-10) : 1355 - 1358
  • [25] Enhancing extemporaneous preparations in Thai Hospitals: exploring variation, common formulations, and challenges and needs related to extemporaneous preparations
    Supapaan, Teeraporn Sadira
    Jamlongpeng, Chinnawat
    Yangyuen, Natthapon
    Srisawai, Komkrit
    Prachuabaree, Lersak
    Wattanawong, Wannaporn
    Anansushatgul, Jirana
    Songmuang, Thanatcha
    Sripa, Saksit
    Pitchayajittipong, Chonladda
    PHARMACY PRACTICE-GRANADA, 2023, 21 (04):
  • [26] Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension
    Foley, Lisa
    Toney, Jennifer
    Barlow, James W.
    O'Connor, Maura
    Fitzgerald-Hughes, Deirdre
    Ramtoola, Zebunnissa
    MOLECULES, 2021, 26 (02):
  • [27] Analysis of extemporaneous oral liquid from commercially available drugs in hospital
    de Lima Benzi, Jhohann Richard
    Mastroianni, Patricia De Carvalho
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (03) : 517 - 525
  • [28] VITAMIN STABILITY IN ORAL MULTIVITAMIN PREPARATIONS
    STONE, GB
    JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1950, 39 (03): : 159 - 162
  • [29] Dermatological extemporaneous preparations in the hospital, practice and pharmacy
    Moll, F
    Deplazes, C
    Panizzon, R
    DERMATOLOGY, 1996, 193 (02) : 160 - 160
  • [30] LIQUID PREPARATIONS OF THEOPHYLLINE FOR ORAL USE
    TOURVILLE, JF
    FINER, MA
    JOURNAL OF PEDIATRICS, 1978, 92 (03): : 514 - 516